Skip to content
Search

Latest Stories

MPs briefed about pharmacies’ unlocked potential in long-term condition prevention

MPs briefed about pharmacies’ unlocked potential in long-term condition prevention

MPs expressed strong agreement with the CPE that the government needs to review pharmacy funding structures  

Community Pharmacy England (CPE) highlighted the untapped potential of community pharmacies in the prevention and management of long-term conditions to Conservative MPs during an event last week.


The roundtable discussion was attended by a select group of influential and supportive MPs alongside community pharmacy owners, the Chief Executive of Community Pharmacy England, the Director of NHS Services, and patient representative group Healthwatch.

MPs in attendance included Steve Double, MP for St Austell and Newquay, who chaired the discussion; Will Quince MP, former Minister for Pharmacy, Derek Thomas MP, Sir Peter Bottomley and Peter Aldous MP.

They talked about the current pressures and funding crisis in community pharmacy, exploring solutions on how this could be eased and the huge benefits that can be unlocked.

CPE Committee members Beran Patel, an independent pharmacy owner, and Jay Patel, Executive Director of Day Lewis, gave their firsthand experiences and perspectives.

Healthwatch also presented its findings on how the public views pharmacies, suggesting that people want pharmacies to offer more services such as vaccinations.

The CPE informed the MPs that community pharmacies can help reduce the burden of long-term conditions if the “current pressures on the sector can be eased.”

CPE CEO Janet Morrison said: “It is critical that we continue to work with MPs to press for solutions to the ongoing intolerable pressures on community pharmacies, but also to show all political parties the very great benefits that pharmacies could offer any new Government if those pressures are addressed.

“This event was another useful way to do that, and it was encouraging to meet with a group of MPs who seemed to so clearly support community pharmacies.

“We’re grateful to Steve Double MP and his parliamentary colleagues for sharing their views and discussing with us what needs to happen to tackle the challenges the sector faces and will be continuing our dialogue with them.”

According to the CPE, the MPs expressed strong agreement with them that the government needs to review “pharmacy funding structures”, and they also demonstrated a keen understanding of the challenges facing frontline pharmacists and pharmacy businesses.

“They agreed that the sector must not be unfairly financially penalised – through fee reductions – for doing too much work,” the CPE said.

During an event last week, the CPE also briefed the Shadow Pharmacy Minister Preet Kaur Gill MP on the need for further investment in the sector.

In their next parliamentary event, scheduled on 12 March, CPE members will be hosting a ‘Model Pharmacy Drop-In’ in partnership with the other national pharmacy organisations.

Pharmacists will be available to demonstrate how they are further helping patients as part of the Pharmacy First service.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less